36 results on '"Schreiber, Andreas"'
Search Results
2. A Prox1 enhancer represses haematopoiesis in the lymphatic vasculature
3. Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer
4. Compound heterozygous variants in LAMC3 in association with posterior periventricular nodular heterotopia
5. Impact of guideline changes on adoption of hypofractionation and breast cancer patient characteristics in the randomized controlled HYPOSIB trial
6. Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial
7. 2D and 3D convolutional neural networks for outcome modelling of locally advanced head and neck squamous cell carcinoma
8. Correction to: Long-term results achieved by guideline-based stage-dependent management of anal cancer in a non-HIV population
9. RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses
10. Aberrant RAG-mediated recombination contributes to multiple structural rearrangements in lymphoid blast crisis of chronic myeloid leukemia
11. Two monogenic disorders masquerading as one: severe congenital neutropenia with monocytosis and non-syndromic sensorineural hearing loss
12. A putative role for the aryl hydrocarbon receptor (AHR) gene in a patient with cyclical Cushing’s disease
13. Identification and targeted management of a neurodegenerative disorder caused by biallelic mutations in SLC5A6
14. Long-term results achieved by guideline-based stage-dependent management of anal cancer in a non-HIV population
15. The Genomic Landscape of Sporadic Prolactinomas
16. The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution
17. Outcome of bowel function following anterior resection for rectal cancer—an analysis using the low anterior resection syndrome (LARS) score
18. A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling
19. Hyperfractionated accelerated radiation therapy plus cetuximab plus cisplatin chemotherapy in locally advanced inoperable squamous cell carcinoma of the head and neck
20. Molecular protein adaptor with genetically encoded interaction sites guiding the hierarchical assembly of plasmonically active nanoparticle architectures
21. Designer amphiphilic proteins as building blocks for the intracellular formation of organelle-like compartments
22. Sequencing error correction without a reference genome
23. Doping – die Züchtung des Übermenschen
24. Transcriptome-scale homoeolog-specific transcript assemblies of bread wheat
25. Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer
26. Discovery of barley miRNAs through deep sequencing of short reads
27. Was ist Doping? Fakten und Probleme der aktuellen Diskussion
28. UNICORE 6 — Recent and Future Advancements
29. Equilibrium desorption isotherms of water, ethanol, ethyl acetate, and toluene on a sodium smectite clay
30. Comparative transcriptomics in the Triticeae
31. Combining transcriptional datasets using the generalized singular value decomposition
32. An atlas of gene expression from seed to seed through barley development
33. Phage Display Selection of HIV Specific Conserved Mimotopes With IgG from Long-term Non-progressors
34. Effect of the Hypoxic Cell Sensitizer Isometronidazole on Local Control of Two Human Squamous Cell Carcinomas after Fractionated Irradiation
35. Genomic autopsy to identify underlying causes of pregnancy loss and perinatal death
36. Two monogenic disorders masquerading as one: severe congenital neutropenia with monocytosis and non-syndromic sensorineural hearing loss
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.